17-3664222-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_ModerateBP6_ModerateBP7
The NM_014604.4(TAX1BP3):āc.210G>Cā(p.Gly70Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000202 in 1,614,008 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 0.00026 ( 0 hom., cov: 33)
Exomes š: 0.00020 ( 1 hom. )
Consequence
TAX1BP3
NM_014604.4 synonymous
NM_014604.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.282
Genes affected
TAX1BP3 (HGNC:30684): (Tax1 binding protein 3) This gene encodes a small, highly conserved protein with a single PDZ domain. PDZ (PSD-95/Discs large/ZO-1 homologous) domains promote protein-protein interactions that affect cell signaling, adhesion, protein scaffolding, and receptor and ion transporter functions. The encoded protein interacts with a large number of target proteins that play roles in signaling pathways; for example, it interacts with Rho A and glutaminase L and also acts as a negative regulator of the Wnt/beta-catenin signaling pathway. This protein was first identified as binding to the T-cell leukaemia virus (HTLV1) Tax oncoprotein. Overexpression of this gene has been implicated in altered cancer cell adhesion, migration and metastasis. The encoded protein also modulates the localization and density of inwardly rectifying potassium channel 2.3 (Kir2.3). To date, this protein has been shown to play a role in cell proliferation, development, stress response, and polarization. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Apr 2017]
P2RX5-TAX1BP3 (HGNC:49191): (P2RX5-TAX1BP3 readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring P2RX5 (purinergic receptor P2X, ligand-gated ion channel, 5) and TAX1BP3 (Tax1 binding protein 3) genes on chromosome 17. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is thus unlikely to produce a protein product. [provided by RefSeq, Mar 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 17-3664222-C-G is Benign according to our data. Variant chr17-3664222-C-G is described in ClinVar as [Benign]. Clinvar id is 1914271.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.282 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAX1BP3 | NM_014604.4 | c.210G>C | p.Gly70Gly | synonymous_variant | 3/4 | ENST00000225525.4 | NP_055419.1 | |
TAX1BP3 | NM_001204698.2 | c.160-337G>C | intron_variant | NP_001191627.1 | ||||
P2RX5-TAX1BP3 | NR_037928.1 | n.5265G>C | non_coding_transcript_exon_variant | 14/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAX1BP3 | ENST00000225525.4 | c.210G>C | p.Gly70Gly | synonymous_variant | 3/4 | 1 | NM_014604.4 | ENSP00000225525.3 | ||
P2RX5-TAX1BP3 | ENST00000550383.1 | n.*3567G>C | non_coding_transcript_exon_variant | 14/15 | 2 | ENSP00000455681.1 | ||||
P2RX5-TAX1BP3 | ENST00000550383.1 | n.*3567G>C | 3_prime_UTR_variant | 14/15 | 2 | ENSP00000455681.1 | ||||
TAX1BP3 | ENST00000611779.4 | c.160-337G>C | intron_variant | 2 | ENSP00000484776.1 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152260Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
39
AN:
152260
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000239 AC: 60AN: 251274Hom.: 0 AF XY: 0.000228 AC XY: 31AN XY: 135874
GnomAD3 exomes
AF:
AC:
60
AN:
251274
Hom.:
AF XY:
AC XY:
31
AN XY:
135874
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000196 AC: 287AN: 1461748Hom.: 1 Cov.: 35 AF XY: 0.000227 AC XY: 165AN XY: 727158
GnomAD4 exome
AF:
AC:
287
AN:
1461748
Hom.:
Cov.:
35
AF XY:
AC XY:
165
AN XY:
727158
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000256 AC: 39AN: 152260Hom.: 0 Cov.: 33 AF XY: 0.000242 AC XY: 18AN XY: 74386
GnomAD4 genome
AF:
AC:
39
AN:
152260
Hom.:
Cov.:
33
AF XY:
AC XY:
18
AN XY:
74386
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at